OPERF
MRNA icon

Oregon Public Employees Retirement Fund’s Moderna MRNA Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
43,421
+3,573
+9% +$185K 0.03% 406
2026
Q1 		$2.02M Buy
39,848
+100
+0.3% +$4.67K 0.03% 508
2025
Q4 		$1.17M Buy
39,748
+200
+0.5% +$5.43K 0.01% 759
2025
Q3 		$1.02M Buy
39,548
+10,137
+34% +$283K 0.01% 834
2025
Q2 		$811K Buy
29,411
+300
+1% +$7.9K 0.01% 891
2025
Q1 		$825K Buy
29,111
+120
+0.4% +$4.26K 0.02% 871
2024
Q4 		$1.21M Buy
28,991
+30
+0.1% +$1.43K 0.02% 694
2024
Q3 		$1.94M Buy
28,961
+310
+1% +$28.5K 0.04% 429
2024
Q2 		$3.4M Buy
28,651
+331
+1% +$41.9K 0.07% 222
2024
Q1 		$3.02M Buy
28,320
+2,387
+9% +$241K 0.06% 278
2023
Q4 		$2.58M Buy
25,933
+325
+1% +$27.3K 0.05% 386
2023
Q3 		$2.65M Buy
25,608
+55
+0.2% +$6.13K 0.04% 458
2023
Q2 		$3.1M Sell
25,553
-50,071
-66% -$6.68M 0.04% 428
2023
Q1 		$11.6M Sell
75,624
-2,871
-4% -$474K 0.14% 161
2022
Q4 		$14.1M Buy
78,495
+7,032
+10% +$1.15M 0.18% 122
2022
Q3 		$8.45M Sell
71,463
-1,726
-2% -$262K 0.12% 192
2022
Q2 		$10.5M Sell
73,189
-116,823
-61% -$16.7M 0.16% 127
2022
Q1 		$32.7M Buy
190,012
+3,565
+2% +$600K 0.34% 53
2021
Q4 		$47.4M Buy
186,447
+47,310
+34% +$13.8M 0.52% 33
2021
Q3 		$53.5M Buy
139,137
+26,991
+24% +$9.95M 0.61% 31
2021
Q2 		$26.4M Sell
112,146
-67,911
-38% -$12.1M 0.3% 61
2021
Q1 		$23.6M Sell
180,057
-109,698
-38% -$15.9M 0.28% 72
2020
Q4 		$30.3M Sell
289,755
-69,496
-19% -$7.03M 0.4% 46
2020
Q3 		$25.4M Buy
359,251
+184,390
+105% +$12.9M 0.37% 48
2020
Q2 		$11.2M Buy
174,861
+150,101
+606% +$8.22M 0.17% 124
2020
Q1 		$742K Sell
24,760
-131,000
-84% -$3.01M 0.01% 846
2019
Q4 		$3.05M Buy
+155,760
New +$2.76M 0.04% 404

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Oregon Public Employees Retirement Fund's MRNA Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Moderna (MRNA) stake by 9% in Q2 2026, buying an estimated $185K and bringing the position to 43,421 shares worth $3.04M. The position accounts for 0.03% of the portfolio, ranked #406.

Oregon Public Employees Retirement Fund first reported a position in MRNA in Q4 2019 and has held it in 27 quarters since. The position peaked at $53.5M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 43,421 shares of Moderna worth $3.04M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 3,573 Moderna shares in Q2 2026, an estimated $185K.
  • Moderna made up 0.03% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #406 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Moderna in Q4 2019 and has held it in 27 quarters since.
  • Oregon Public Employees Retirement Fund's Moderna position peaked at $53.5M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.